Insulin-like growth factor-1 (IGF-1, upregulated about 3-fold) has been noted to increase in concentration in the cerebrospinal fluid of patients with infantile Batten disease [24], and has been used to delay interneuron loss in the mnd model of Batten disease [25]. The gene discussed is IGF1; the disease is juvenile neuronal ceroid lipofuscinosis.